Home › Neuroendocrine Tumors › Pennsylvania › Philadelphia
Neuroendocrine Tumors clinical trials in Philadelphia, PA
11 studies for Neuroendocrine Tumors are looking for participants at sites in and around Philadelphia (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
RecruitingPhase 2/3
- University of Pennsylvania, Philadelphia
Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
RecruitingPhase 1
- The Children's Hospital of Philadelphia (CHOP), Philadelphia
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
RecruitingPhase 3
- Hospital of the University of Pennsylvania, Philadelphia
Project: Every Child for Younger Patients With Cancer
RecruitingObservational study
- Drexel University School of Medicine, Philadelphia
- Children's Hospital of Philadelphia, Philadelphia
- Saint Christopher's Hospital for Children, Philadelphia
- and 1 more
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
RecruitingPhase 1/2
- Crinetics Study Site, Philadelphia
- Crinetics Study Site, Philadelphia
Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors
RecruitingPhase 2
- Fox Chase Cancer Center, Philadelphia
CapTemY90 for Grade 2/3 NET Liver Metastases
RecruitingPhase 2
- University of Pennsylvania, Philadelphia
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
RecruitingPhase 1/2
- University of Pennsylvania, Philadelphia
A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy
RecruitingPhase 1/2
- University of Pennsylvania, Philadelphia
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
RecruitingPhase 4
- Albert Einstein Healthcare Network, Philadelphia
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Philadelphia
Neuroendocrine Tumors trials in other cities
- Washington, DC11 studies
- Rochester, MN9 studies
- Houston, TX8 studies
- St. Louis, MO7 studies
- Chicago, IL7 studies
- Columbus, OH7 studies
- Cleveland, OH7 studies
- Detroit, MI7 studies
- Salt Lake City, UT7 studies
- Dallas, TX6 studies
- Charlottesville, VA6 studies
- New York City, NY6 studies
Other studies in Philadelphia
- Cancer (all types)59 studies
- Breast Cancer56 studies
- Non-Small Cell Lung Cancer51 studies
- Metastatic Cancer46 studies
- Prostate Cancer44 studies
- Colorectal Cancer44 studies
- Ovarian Cancer44 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia34 studies
- Heart Failure31 studies
- Endometrial Cancer28 studies
- Depression26 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.